Can tablets and VR better capture how eye disease affects daily life?
NCT ID NCT07489898
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
Standard eye tests often miss the real-world vision problems people face, like trouble recognizing faces or navigating in low light. This study will test new tablet and virtual reality tools in 50 adults with neurodegenerative eye diseases to see if they better capture how vision affects quality of life. The goal is to improve how future treatments are evaluated in clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to better ways of measuring vision in clinical trials, helping to develop more effective treatments for eye diseases.
What could go wrong
This is a small, early feasibility study with only 50 participants. The new tests may not prove more useful than current methods, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEURODEGENERATIVE DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••